Laminin subunit gamma 1 (LAMC1) mRNA (LAMC1 mRNA)

Laminin subunit gamma 1 (LAMC1) mRNA encodes the gamma-1 chain, a critical component of various laminin heterotrimers such as laminin-111 and laminin-511, which are essential for basement membrane structural integrity and cell-matrix interactions (UniProt P11047; NCBI Gene ID: 3915). The LAMC1 protein facilitates cell adhesion, migration, and signaling pathways that regulate tissue development and homeostasis (Domogatskaya et al., 2012). In pathological contexts, LAMC1 mRNA is frequently overexpressed in several malignancies, including gastric, colorectal, and hepatocellular carcinomas, where it promotes the epithelial-mesenchymal transition (EMT), tumor invasion, and metastasis (Huang et al., 2017; Liu et al., 2022). Beyond oncology, LAMC1 has been implicated in the pathogenesis of endometriosis and uterine leiomyomas, where its dysregulation contributes to abnormal tissue remodeling (Kikkawa et al., 2004). Consequently, LAMC1 mRNA has emerged as a potential therapeutic target, with experimental approaches utilizing RNA interference (RNAi) or antisense oligonucleotides (ASOs) to silence its expression and inhibit disease progression (Wang et al., 2021). While no LAMC1-targeted therapies are currently FDA-approved, preclinical studies demonstrate that reducing LAMC1 levels can significantly impair tumor growth and enhance sensitivity to other treatments (Liu et al., 2022). Therapeutic challenges include ensuring the specificity of RNA-targeted agents to avoid off-target effects and maintaining the integrity of normal basement membranes in healthy tissues (Domogatskaya et al., 2012).

Other names

Laminin subunit gamma-1 mRNALaminin B2 chain mRNALaminin-1 subunit gamma mRNALaminin-10 subunit gamma mRNALAMC1 transcript

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to prevent translation of the LAMC1 protein.